Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.
Episode: 12 - Todd Przybycien on Precipitation As Antibody Capture
In the latest episode of Bioprocessing Unfiltered, Bill Whitford talks with Todd Przybycien about using precipitation as a continuous capture step for monoclonal antibody downstream processing, and why higher titers make the approach practical again. We dig into step change improvements in cost of goods, throughput, footprint, and sustainability, plus what it takes to control and automate a continuous process. Join us to hear: • Todd’s early downstream processing work and why “un...
1 Sept 2026
Episode: 11 - Anthony Mire-Sluis on Where AI Fits in Quality
Quality leaders are increasingly tasked with deciding where and how AI can add value without compromising quality. In this episode, Anthony Mire-Sluis, Ph.D., senior vice president of global quality at Gilead Sciences, and host Ran Zheng discuss navigating the intersection of quality, digital transformation, and AI in biopharmaceutical manufacturing. They explore how leaders can determine whether a process is ready for digitalization, avoid common implementation mistakes, and distinguish betw...
4 Aug 2026
Episode: 10 - Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis
Everyone wants smarter bioprocessing, yet most teams are still fighting the same battle they fought years ago: inconsistent information, messy process data, and systems that were never designed to support analysis. At this year's Bioprocessing Summit Europe, industry experts gathered on a panel to address these gaps, explore why data challenges persist, and discuss why the hardest part is often data engineering and harmonization. Moderated by Maximilian Krippl, Ph.D., head of bioprocess model...
2 Jun 2026
Episode: 9 - Jack Scarcelli on Moving Beyond One Host, One Vector, One Process for Today’s Cell Line Development
In this episode of Bioprocessing Unfiltered, Jack Scarcelli, senior director and head of cell line development at Sanofi, speaks with host Hussain Dahodwala, professor of upstream process development at University of Maryland’s Institute of Bioscience and Biotechnology Research, to discuss technical and strategic challenges in the next gen cell line development in the biopharmaceutical industry. Scarcelli traces his career journey, shares lessons learned over a successful career, and offers t...
5 May 2026
Episode: 8 - Jack Prior of Sanofi on AI Readiness in Biomanufacturing
In this episode of Bioprocessing Unfiltered, Jack Prior, head of process monitoring and data science and AI strategy at Sanofi, explores how AI has evolved from early expert systems to machine learning, generative AI, and agentic AI, and what that means for biomanufacturing today. He explains why digital transformation has not automatically created usable data, and why the real challenge is turning fragmented information from manufacturing systems into accessible, authentic, and analysis-read...
8 Apr 2026
Episode: 7 - Anurag Rathore on Platform Processes, Chromatography, and Expanding Education
Anurag Rathore, professor of chemical engineering at the Indian Institute of Technology Delhi, joins Bioprocessing Unfiltered with host Alois Jungbauer to discuss his long career in advancing bioprocessing engineering. Rathore shares his thoughts on chromatography, using platform processes to accelerate process development, how infinity capture can be a way to arrive at platform processes, and if there is a need for alternative methods. He also explores updates needed to the traditional curri...
10 Mar 2026
Episode: 6 - Fireside Chat: Innovation and Investment in Biomanufacturing of Future Medicine
At the most recent Bioprocessing Summit, David Y. H. Chang, CEO of Taiwan Bio-Manufacturing Company; Bo Wiinberg, Chief Business Development Officer of Novo Nordisk Foundation Cellerator; and Paul Lewus, Vice President of Site Operations at Amgen gathered for a fireside chat moderated by Ran Zheng, former CEO of Landmark Bio, to discuss the technologies and innovations shaping the future of biomanufacturing. The conversation explored upcoming trends, investment opportunities, and modalities i...
3 Feb 2026
Episode: 5 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations, Part 2
Picking up from their previous conversation on Bioprocessing Unfiltered, Andrew Sinclair, president and founder of BioPharm Services Ltd., and host William Whitford, founder of Oamaru BioSystems, discuss improving manufacturing efficiency, including process mass intensity and setting up parameters, and more on Sinclair’s long career and valuable experiences in the industry. Sinclair also shares advice on helping someone who cannot meet parameters, how to navigate new profusions, and default v...
6 Jan 2026
Episode: 4 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations - Part 1
How can we optimize manufacturing and operations? In this episode of Bioprocessing Unfiltered, Andrew Sinclair, president and founder of Biopharm Services, provides insight from his 35-year-long career in the industry on the most significant ways data management and predictive modeling can improve efficiency during the manufacturing process. With host William Whitford, founder of Oamaru BioSystems, Sinclair delves into the history and impact of costs, how to handle evolving efficiencies, and ...
2 Dec 2025
Episode: 3 - The Future of Gene Therapies and CDMOs with Philip Ramsey
What is the future of gene therapies? In this episode of Bioprocessing Unfiltered, host Susan D’Costa, chief technical and commercial officer of Genezen, and Phillip Ramsey, CTO of Sangamo Therapeutics, discuss a variety of topics about gene therapies, including what will transform viral vector gene therapy, the evolving role of contract development and manufacturing organizations (CDMOs), and how gene editing in general fits into the broader gene therapy landscape. Plus, they cover the three...
4 Nov 2025
Episode: 2 - Georges Belfort Discusses Breakthroughs in mRNA Purification
What makes mRNA purification different from other bioprocessing methods? In this episode of Bioprocessing Unfiltered, host Alois Jungbauer, professor and head of biotechnology at the Institute of Bioprocess Science and Engineering at BOKU University, speaks with Georges Belfort, institute professor of chemical and biological engineering at Rensselaer Polytechnic Institute about his research in mRNA purification and his long, illustrious career in the industry, including the impact of his disc...
3 Oct 2025
Episode: 1 - Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies
Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinberg, chief business development officer at Novo Nordisk Foundation Cellerator, sat with Ran Zheng, CEO of Landmark Bio and shared his expert insight on the promise cell therapies hold for diseases with only treatments but no cures. Their conversation covers the challenges of navigating cell therapy programs through pre-clinica...
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Spotify
5.0 / 5
1 ratings
Contact Bioprocessing Unfiltered
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Bioprocessing Unfiltered?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
